- Home
- SHMD vs RGC Comparison
SHMD vs RGC Comparison
Compare SHMD & RGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SHMD | RGC |
|---|---|---|
| Founded | 1864 | 2014 |
| Country | Germany | Hong Kong |
| Employees | N/A | N/A |
| Industry | | Medicinal Chemicals and Botanical Products |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 198.2M | 3.1B |
| IPO Year | 2023 | 2020 |
Fundamental Metrics
Financial Performance| Metric | SHMD | RGC |
|---|---|---|
| Price | $4.42 | $6.37 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 1.2M | 155.6K |
| Earning Date | 05-15-2026 | 10-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $49.82 | N/A |
| Revenue Next Year | $36.39 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.34 | $4.51 |
| 52 Week High | $10.65 | $69.00 |
Technical Indicators
Market Signals| Indicator | SHMD | RGC |
|---|---|---|
| Relative Strength Index (RSI) | 67.93 | 54.01 |
| Support Level | $4.78 | $5.48 |
| Resistance Level | $7.36 | $6.28 |
| Average True Range (ATR) | 0.40 | 0.28 |
| MACD | 0.21 | 0.05 |
| Stochastic Oscillator | 88.66 | 80.43 |
Price Performance
Historical ComparisonAbout SHMD SCHMID Group N.V. Class A Ordinary Shares
Schmid Group NV is a supplier of equipment, software and services for various industries such as printed circuit board (PCB), substrate manufacturing, photovoltaics, and glass and energy storage with a focus on the highest end of this market in terms of technology and performance. It focuses on a modular product portfolio of machinery to use in the manufacturing of high-end PCB equipment and semiconductor packaging devices which includes common flexible circuit fabrication techniques such as subtractive, semi-additive processes (SAP) and modified semi-additive processes (mSAP).
About RGC Regencell Bioscience Holdings Limited
Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.